Clinical Trial Update: High Dose Oral Versus Intramuscular Vitamin D3 Supplementation In Multiple Sclerosis Patients [NA]

View source ↗

Summary

This trial compares high-dose oral vitamin D3 versus intramuscular vitamin D3 supplementation in relapsing-remitting multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Relapsing Remitting Multiple Sclerosis | NA | Status: COMPLETED